Work-Related Stress Linked to Lower Odds of Average, Optimal Heart Health
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 6, 2024 -- Work-related stress is associated with lower odds of having average and optimal cardiovascular health (CVH), according to a study published online Nov. 6 in the Journal of the American Heart Association.
Oluseye Ogunmoroti, M.D., M.P.H., from the Rollins School of Public Health at Emory University in Atlanta, and colleagues examined the association between work-related stress and CVH in a multiethnic sample of adults free from cardiovascular disease at baseline. The cross-sectional analysis included 3,579 men and women aged 45 to 85 years from the Multi-Ethnic Study of Atherosclerosis. A self-administered questionnaire was used to assess work-related stress. The American Heart Association Life's Simple 7 metrics were used to measure CVH, with each metric contributing 0, 1, or 2 points if in the poor, intermediate, or ideal range, respectively.
The researchers found that 20 percent of participants reported work-related stress. Compared with those without work-related stress, participants with work-related stress had lower odds of having average and optimal CVH scores (adjusted odds ratios, 0.75 and 0.73, respectively) in fully-adjusted models.
"Our findings support the importance of workplace wellness programs designed to manage stress, promote CVH, and reduce the risk of cardiovascular disease events," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-07 06:00
Read more
- AHA: Rising Outdoor Temperatures Tied to Higher Risk for Atrial Fibrillation
- How a Move Away From Beef Could Help the Planet
- USPSTF Recommends Early Screening for Syphilis in Pregnancy
- Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023
- Colonoscopy Still Beats New Blood Tests at Spotting Colon Cancer
- Virtual Yoga Classes Aid Chronic Low Back Pain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions